Ultrasound imaging highlighted tumor development on the left lung surface, and proteomic analysis identified specific biomarkers associated with lung cancer, such as ADAMTS12, BRAF, BRCA2, and TIF1α. This evidence concerns the gene BRCA2 and lung carcinoma.